期刊文献+

老年抑郁症的精神影像学客观标记物及其临床应用 被引量:2

The Objective Marker of Mental Imaging in Geriatric Depression and its Clinical Application
下载PDF
导出
摘要 基于国内外对老年抑郁症的研究成果,文章主要对老年抑郁症的精神影像学客观标记物及其临床应用的问题进行了研究。首先,本文综述了研究的背景、目的和意义,进而对生物标记物的概念内涵进行了界定。其次,系统阐述了老年抑郁症的SMRI、FMRI、DTI的脑区脑网络变化,并在此基础上结合精神影像的客观标记物临床实际应用。通过本文的研究,得到以下结论:老年抑郁症患者在额叶-纹状体-边缘网络中的灰质体积明显降低,支持默认网络失活或者过度激活都与老年抑郁症网络机制相关,且与临床表现以及治疗预后呈一定关系。考虑将上述环路以及脑网络功能性连接变化作为老年抑郁症生物标记物。 Based on the research results of geriatric depression at home and abroad, this paper mainly studies the problems of the objective marker and its clinical application of the psychiatric imaging of geriatric depression. Firstly, this paper summarizes the background, purpose and significance of the research, and then defnes the concept of biomarkers. Secondly, we systematically describe the changes of brain area and network in SMRI, FMRI and DTI of geriatric depression, finally, we summarize the brain changes based on the clinical application of objective marker of psychiatric imaging. We get the following conclusion Patients of geriatric depression had lower grey matter volumes in the fronto-striatal-limbic networks. We supported the default network inactivation or over activation, which were all related to the network mechanism of geriatric depression, and were related to clinical manifestations and prognosis. We should consider the above loop and functional connectivity changes of brain network as biomarkers.
作者 王欣越 杨媛 WANG Xinyue;YANG Yuan(State Key Laboratory of Oral Diseases / National Clinical Research Center for Oral Diseases / West China School of Stomatology, Sichuan University, Chengdu Sichuan 610041, China)
出处 《中国卫生标准管理》 2018年第9期122-124,共3页 China Health Standard Management
关键词 老年抑郁症 神经结构和功能 精神影像学 客观标记物 geriatric depression neural structure and function neuroimaging objective maker
  • 相关文献

参考文献3

二级参考文献65

  • 1丁冬红,何海霞,吴殿龙.认知行为疗法对老年抑郁症的治疗作用[J].临床精神医学杂志,2004,14(5):298-298. 被引量:29
  • 2卫永琪.中医辨证治疗老年抑郁症[J].四川中医,2004,22(12):44-45. 被引量:7
  • 3王红,周铌,左俊英,梅乔生,陈世蓉.老年抑郁症的心理社会因素研究进展[J].老年医学与保健,2005,11(3):184-186. 被引量:28
  • 4Collins PY, Patel V, Joestl SS, et al. Grand challenges in global mental health [ J ]. Nature, 2011, 475 ( 7354 ) : 27-30. doi : 10. 1038/475027 a.
  • 5Risch N, Herrell R, Lehner T, et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a recta-analysis[ J]. JAMA, 2009, 301 (23) : 2462-2471. doi : 10. 1001/jama. 2009. 878.
  • 6Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis[ J]. Lancet, 2013, 381 ( 9875 ) : 1371-1379. doi : 10. 1016/S0140-6736 ( 12 ) 62129-1.
  • 7Cross-Disorder Group of the Psychiatric Genomics Consortium, Lee SH, Ripke S, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet, 2013,45 (9) :984-994. doi: 10. 1038/ng. 2711.
  • 8Ripke S, Wray NR, Lewis CM, et al. A mega-analysis of genome- wide association studies for major depressive disorder [ J ]. Mol Psychiatry, 2013, 18 (4) :497-511. doi : 10. 1038/mp. 2012.21.
  • 9Savitz JB, Rauch SL, Drevets WC. Clinical application of brain imaging for the diagnosis of mood disorders: the current state of play[ J ]. Mol Psychiatry, 2013, 18 ( 5 ) :528-539. doi : 10. 1038/ too. 2013.25.
  • 10De Gruttola VG, Clax P, DeMets DL, et al. Considerations in the evaluation of surrogate endpoints in clinical trials, summary of a National Institutes of Health workshop [ J ]. Control Clin Trials, 2001, 22(5) :485-502.

共引文献12

同被引文献30

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部